Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tezacaftor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Symdeko

    02 2Symdeko

    03 3Symdeko/Symkevi

    04 2Trikafta

    05 3Trikafta/Kaftrio

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Trikafta

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Trikafta

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2019 Revenue in Millions : 420

    2018 Revenue in Millions : 0

    Growth (%) : New launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Symdeko

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Symdeko

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2019 Revenue in Millions : 1,418

    2018 Revenue in Millions : 769

    Growth (%) : 84

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Trikafta

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Trikafta

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2020 Revenue in Millions : 3,864

    2019 Revenue in Millions : 420

    Growth (%) : 820

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Symdeko

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Symdeko

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2020 Revenue in Millions : 629

    2019 Revenue in Millions : 1,418

    Growth (%) : -56

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Trikafta/Kaftrio

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Trikafta/Kaftrio

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 5,697

    2020 Revenue in Millions : 3,864

    Growth (%) : 32

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Symdeko/Symkevi

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Symdeko/Symkevi

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 420

    2020 Revenue in Millions : 629

    Growth (%) : -50

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Trikafta/Kaftrio

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Trikafta/Kaftrio

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2022 Revenue in Millions : 7,687

    2021 Revenue in Millions : 5,697

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Symdeko/Symkevi

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Symdeko/Symkevi

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2022 Revenue in Millions : 180

    2021 Revenue in Millions : 420

    Growth (%) : -57

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Symdeko/Symkevi

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Symdeko/Symkevi

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2023 Revenue in Millions : 123

    2022 Revenue in Millions : 180

    Growth (%) : -46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Trikafta/Kaftrio

    Tezacaftor

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Trikafta/Kaftrio

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Vertex

    Tezacaftor

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2023 Revenue in Millions : 8,945

    2022 Revenue in Millions : 7,687

    Growth (%) : 14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF